Helicobacter pylori and Microcirculation

被引:9
|
作者
Suzuki, Hidekazu [1 ]
Suzuki, Masayuki
Imaeda, Hiroyuki [2 ]
Hibi, Toshifumi
机构
[1] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, Tokyo 1608585, Japan
[2] Keio Univ Hosp, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, Tokyo, Japan
基金
日本学术振兴会;
关键词
microcirculation; H; pylori; gastric mucosa; endothelial cell; platelet; leukocyte; cytokine; GASTRIC-MUCOSAL MICROCIRCULATION; CENTRAL SEROUS CHORIORETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; UREASE IMMUNOGLOBULIN-Y; ALPHA-METHYL HISTAMINE; CORONARY HEART-DISEASE; MONGOLIAN-GERBILS; IN-VIVO; CONGESTIVE GASTROPATHY; LEUKOCYTE ACTIVATION;
D O I
10.1080/10739680902949953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microcirculation is one of the susceptible targets in the pathogenesis of disorders caused by exogenous pathogens, such as the well-known bacterium, Helicobacter pylori (Hp). While extensive studies have been published on the kinetics of Hp infection, only a few have dealt with the microcirculatory aspects of Hp-induced disorders. This review summarizes the recent developments in the elucidation of the pathophysiology of disorders. This review summarizes the recent developments in the elucidation of the pathophysiology of disorders caused by Hp infection, focusing on the microcirculatory aspect. Animal and human studies were systematically reviewed to identify published data on the microcirculatory aspects of Hp infection. This updated summary of the microcirculatory aspects of Hp-induced disorders illustrates potential approaches that might be used to clarify the pathophysiology of the gastric and extragastric sequelae of Hp infection and the therapeutic strategies that could be adopted. Microcirculation (2009) 16, 547-558. doi:10.1080/10739680902949953
引用
收藏
页码:547 / 558
页数:12
相关论文
共 50 条
  • [21] Experiences with Helicobacter Pylori Treatment in Iran
    Saberi-Firoozi, M.
    Nejabat, M.
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2006, 31 (04) : 181 - 185
  • [22] Helicobacter pylori and NSAIDs -: What interaction
    McCarthy, DM
    EUROPEAN JOURNAL OF SURGERY, 2001, 167 : 56 - 65
  • [23] Helicobacter pylori and extragastric diseases: A review
    Gravina, Antonietta Gerarda
    Zagari, Rocco Maurizio
    De Musis, Cristiana
    Romano, Lorenzo
    Loguercio, Carmelina
    Romano, Marco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (29) : 3204 - 3221
  • [24] Helicobacter pylori infection and gastric cancer
    Sugiyama T.
    Asaka M.
    Medical Electron Microscopy, 2004, 37 (3): : 149 - 157
  • [25] Sequential therapy for Helicobacter pylori eradication
    Yakut, Mustafa
    Cinar, Kubilay
    Seven, Gulseren
    Bahar, Kadir
    Ozden, Ali
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (03) : 206 - 211
  • [26] Helicobacter pylori: a sexually transmitted bacterium?
    Dimitriadi, Dimitra
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2014, 67 (04) : 407 - 409
  • [27] Helicobacter pylori in patients with hepatic encephalopathy
    Shaikh, S.
    Devrajani, B. R. D.
    Shah, S. Z. A.
    Shaikh, M. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 150 - 150
  • [28] Helicobacter pylori and recurrent pain abdomen
    Biswal N.
    Ananathakrishnan N.
    Kate V.
    Srinivasan S.
    Nalini P.
    Mathai B.
    The Indian Journal of Pediatrics, 2005, 72 (7) : 561 - 565
  • [29] Surgical implications of Helicobacter pylori infection
    Clarke, KO
    Harrison, LE
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : E119 - E128
  • [30] Optimizing the growth of stressed Helicobacter pylori
    Richards, Crystal L.
    Buchholz, Brittany J.
    Ford, Timothy E.
    Broadaway, Susan C.
    Pyle, Barry H.
    Camper, Anne K.
    JOURNAL OF MICROBIOLOGICAL METHODS, 2011, 84 (02) : 174 - 182